Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002068421-25-000001
Filing Date
2025-05-15
Accepted
2025-05-15 14:01:59
Documents
1
Effectiveness Date
2025-05-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9148
  Complete submission text file 0002068421-25-000001.txt   10267
Mailing Address 329 OYSTER POINT BLVD. 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD. 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-239-0503
Shenandoah Therapeutics Inc. (Filer) CIK: 0002068421 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-546256 | Film No.: 25951299